Ladrx Stock Cash And Equivalents
LadRx fundamentals help investors to digest information that contributes to LadRx's financial success or failures. It also enables traders to predict the movement of LadRx OTC Stock. The fundamental analysis module provides a way to measure LadRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LadRx otc stock.
LadRx |
LadRx OTC Stock Cash And Equivalents Analysis
LadRx's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current LadRx Cash And Equivalents | 4.11 M |
Most of LadRx's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LadRx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, LadRx has 4.11 M in Cash And Equivalents. This is 99.5% lower than that of the Healthcare sector and 99.08% lower than that of the Biotechnology industry. The cash and equivalents for all United States stocks is 99.85% higher than that of the company.
LadRx Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LadRx's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of LadRx could also be used in its relative valuation, which is a method of valuing LadRx by comparing valuation metrics of similar companies.LadRx is currently under evaluation in cash and equivalents category among its peers.
LadRx Fundamentals
| Return On Equity | -1.64 | ||||
| Return On Asset | -0.34 | ||||
| Current Valuation | 7.5 M | ||||
| Shares Outstanding | 45.04 M | ||||
| Shares Owned By Insiders | 9.76 % | ||||
| Shares Owned By Institutions | 9.30 % | ||||
| Number Of Shares Shorted | 294.31 K | ||||
| Price To Book | 8.48 X | ||||
| Price To Sales | 34.48 X | ||||
| EBITDA | (5.97 M) | ||||
| Net Income | (13.18 M) | ||||
| Cash And Equivalents | 4.11 M | ||||
| Cash Per Share | 0.09 X | ||||
| Total Debt | 322.33 K | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 1.83 X | ||||
| Book Value Per Share | (0.01) X | ||||
| Cash Flow From Operations | (12.31 M) | ||||
| Short Ratio | 1.96 X | ||||
| Beta | 2.07 | ||||
| Market Capitalization | 4.32 M | ||||
| Total Asset | 8.73 M | ||||
| Z Score | 7.8 | ||||
| Net Asset | 8.73 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in unemployment. Note that the LadRx information on this page should be used as a complementary analysis to other LadRx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in LadRx OTC Stock
If you are still planning to invest in LadRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LadRx's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |